Australian Cancer Technology (ASX:ACU) has completed the acquisition of a range of nutraceuticals designed specifically for cancer patients undergoing treatment. [ + ]

New Zealand's biotechnology industry will emerge into the sunlight next week, after the NZ Parliament voted decisively to end the nation's moratorium on field trials of genetically modified organisms (GMOs). [ + ]

Researchers believe they have solved a serious problem faced by the medical community with the most important antibiotics in general use today, the b-lactam family of products: the increasing development of drug resistance.

UK biomedical research charity the Wellcome Trust has joined the governments of Australia and New Zealand to launch a series of health initiatives that could help save the lives of millions of people in the Asia-Pacific region.

Virax's share price (ASX:VHL) soared 28 per cent today on heavy trading after the company released good results for its HIV immunotherapy Phase IIa clinical trial. [ + ]

Adelaide-based biotech GroPep is to receive AUD$3.8 million from the Gates Foundation-funded Malaria Vaccine Initiative (MVI) and the Program for Appropriate Technology in Health (PATH), after meeting the first milestone in a project inherited from Biotech Australia. [ + ]

Ocean forecasting information will soon be available to serve Australians in the same way atmospheric weather forecasting has delivered for on-land populations, following the recent announcement of a $15 million Australian Government initiative.

Dr Peter Smith, a British-born former biotech analyst and company founder, has been named as the new CEO of Melbourne firm Amrad (ASX:AML) at its annual general meeting today. [ + ]

Genetic Technologies (ASX:GTG) has formed a strategic alliance with the Perth-based CY O'Connor ERADE Village Foundation that is intended to strengthen GTG's already formidable -- and controversial -- grip on gene testing using non-coding DNA sequences. [ + ]

Industry association AusBiotech is moving to cement its role as an advocate for Australia's biotechnology industry, with the appointment of former SDA Biotech principal Paris Brooke to a newly created role in policy and communications. [ + ]

Drug reengineering company Eiffel Technologies has recruited former PowderJect technologies manager Dr Pascal Hickey as chief operating officer. [ + ]

In a drastic move to raise more funds for medical research, Monash University has sold off 6 million of its shares in promising Victorian biotech Metabolic Pharmaceuticals (ASX:MBP). [ + ]

Australia risks being left out in the cold if it doesn't participate in efforts to sequence the marsupial genome, say leading genomics scientists who are trying to raise AUD$5 million in support of Australian participation. [ + ]

Adelaide biotech Bionomics (ASX:BNM, US OTC:BMICV)) has filed a provisional patent application on a DNA diagnostic test for a benign form of epilepsy that causes seizures in early childhood. [ + ]

Scientist at a British company have discovered a way of making the glass plates used in laboratories 200 times more effective.